)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Jamia Millia Islamia suspends all MoUs with institutions linked to Turkiye, joining JNU and CSJM in response to growing concerns over national security and diplomacy
Analysts say IHH's reputational harm claim in Japan won't impact Fortis's Indian operations; litigation continues over stalled open offer and regulatory hurdles
Monthly CDSCO alert identifies 196 batches of drugs as not of standard quality and flags one Deca-Durabolin injection as spurious and under investigation
The hospital chain's revenue rose 12.4% to Rs 2,007 crore in Q4 FY25 driven by hospital and diagnostics segments, but higher expenses and impairments hit net profit
India records 164 new Covid-19 cases between May 12 and 19, with Kerala, Tamil Nadu and Maharashtra reporting most cases; officials say symptoms remain mild
IHH arm NTK raises damages claim against Daiichi Sankyo to Rs 11,800 crore, alleging obstruction of Fortis Healthcare acquisition via stalled open offer
Projects like The Dahlias and Privana West fuelled DLF's FY25 sales to a record Rs 21,223 crore, with strong demand from domestic buyers and NRIs
Profit growth driven by higher occupancy, rising Arpob, international patient inflow and new bed additions across Lucknow, Dwarka and BLK Max facilities
Lupin plans to expand complex generics in developed markets and grow its chronic drug portfolio in India, with over 200 product launches and M&A on the radar
Fully AI-integrated project in Greater Noida
DLF posts robust Q4FY25 results with 39% rise in profit and 46% growth in revenue, driven by record sales from luxury projects and steady rental performance
Govt says Covid-19 situation remains under control despite a minor uptick in cases, amid rising infections in Singapore and Hong Kong attributed to Omicron subvariants
Doctors advise calm as India sees just 58 new Covid-19 cases amid a rise in HK and Singapore; experts highlight low hospitalisation and no serious strain currently
Data centres and hospitals are key growth drivers for EPC firm Capacit'e Infraprojects as it enters global markets after its first international project in Maldives
Firm looks to stay in its core mid-size project segment
Global Health reports Q4FY25 PAT drop to ₹101.4 crore on one-time expense; revenue up 15% to ₹931.2 crore; expansion plans include 550-bed Noida facility by FY26
Realty firm Signature Global saw a record ₹10,290 crore in FY25 pre-sales despite a Q4 revenue decline caused by project launch delays due to pending approvals
The company's revenue from operations rose 14.2 per cent Y-o-Y to ₹5,671 crore, from ₹4,961 crore in Q4FY24
Sanofi India's Q4FY25 profit declined 12.5% Y-o-Y to ₹119.5 crore, while revenue rose 4.9%; operating profit improved 27% on better efficiency, says CFO
India accounts for 26 per cent of global TB burden; PM highlights technology use, infrastructure expansion and targeted outreach as key to meeting 2025 goal